Malaria Funders Information Package
A comprehensive guide to funding pathways, eligibility criteria, and application processes for malaria control programs.
| Funders | |
|---|---|
| … | |
^ These financial data are preliminary and subject to change. The discretionary vaccine budget, which includes funding for malaria vaccines, will be reviewed at the July Gavi Board. Gavi support is calculated based on the current forecast. These figures may include a different transition period for countries to reach 70% implementation compared to previous communications to countries.
* The color coding reflects the country potential to reach a minimum 70% scale (of moderate and high transmission areas) within their Gavi discretionary vaccine budget (green – yes; amber – requires additional financing). This does not include consideration for secured self-financing or other confirmed external financing source for malaria vaccines. These data do not reflect country prioritization decisions.
** Nigeria has potential to scale to level of country ambition at time of current forecast.
*** Multicountry Funds: Diseases don't respect borders. Sometimes the most effective solution is one that brings together several countries or regions. Through multicountry funding, the Global Fund addresses a limited number of key multicountry priorities deemed critical to fulfill the aims of the Global Fund strategy. These catalytic investments complement those made through the Global Fund's allocation methodology.
- Multicountry East Asia and Pacific RAI2: Includes Cambodia, Lao (People's Democratic Republic), Myanmar, Thailand and Vietnam. These countries are part of the Regional Artemisinin-resistance Initiative program (RAI), which will also receive US$10,000,000 of catalytic multicountry funding.
- Multicountry Middle East MER3: Includes Iraq, Lebanon, Libya, Palestine, Syrian Arab Republic and Yemen.
- Multicountry Western Pacific5: Includes Fiji, Kiribati, Marshall Islands, Micronesia (Federated States), Samoa, Tonga, Tuvalu and Vanuatu.